| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000025065 |
| Receipt No. | R000028837 |
| Official scientific title of the study | Phase II clinical trial for the effectiveness and safety of AW-PD01 (helium / oxygen mixed gas) for respiratory failure in children and infants with airway stenotic lesions: Single facility single group open label intervention study |
| Date of disclosure of the study information | 2016/12/01 |
| Last modified on | 2017/02/08 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Phase II clinical trial for the effectiveness and safety of AW-PD01 (helium / oxygen mixed gas) for respiratory failure in children and infants with airway stenotic lesions: Single facility single group open label intervention study | |
| Title of the study (Brief title) | Helium-Oxygen gas clinical trial for infant with obstructive airway disease | |
| Region |
|
|
| Condition | |||
| Condition | Respiratory failure, Bronchiolitis | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Comparing the effectiveness and safety for respiratory failure in Japanese children / infants with obstructive airway disease between AW-PD01 (helium/oxygen mixed gas) therapy and existing therapy |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Airway resistance |
| Key secondary outcomes | PaCO2, tidal volume, lung compliance, the product of PaCO2 and driving pressure, length of ICU stay, length of intubation, safety |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Heliox | |
| Interventions/Control_2 | Air | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients who are diagnosed with acute bronchiolitis due to clinical symptoms (tachypnea, cough, extension of expiration time, exhalation wheezing, rale sounds and increasing work of breathing ), chest X-ray (pulmonary hyperinflation)
2. Hospitalized patients in intensive care unit 3. Patients who receive mechanical ventilation 4. written informed consent is obtained from the parent |
|||
| Key exclusion criteria | 1. With cyanotic heart disease
2. With chronic lung disease 3. Receiving a diagnosis of bronchial asthma 4. patients who are judged unsuitable as subjects of the examination by the attending doctor |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Naoki Shimizu |
| Organization | Tokyo Metropolitan Children's Medical Center |
| Division name | Department of Crtical Care Medicine |
| Address | 2-8-29, Musashidai, Fuchu city, Tokyo, Japan |
| TEL | 042-300-5111 |
| naoki_shimizu@me.com | |
| Public contact | |
| Name of contact person | Kenji Morimoto |
| Organization | Tokyo Metropolitan Children's Medical Center |
| Division name | Department of Crtical Care Medicine |
| Address | 2-8-29, Musashidai, Fuchu city, Tokyo, Japan |
| TEL | 042-300-5111 |
| Homepage URL | |
| kjas09100728@gmail.com | |
| Sponsor | |
| Institute | Tokyo Metropolitan Children's Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Center for Clinical Trials, Japan Medical Association |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028837 |